Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Moving Beyond the Assumed: Improving Fistula Success Rates.

Literature DB >> 28733368

Moving Beyond the Assumed: Improving Fistula Success Rates.

Jay B Wish¹, Sharon M Moe^2,3.

Abstract

Entities: Disease

Keywords: arteriovenous fistula; hemodialysis; hemodialysis access

Mesh：

Year: 2017 PMID： 28733368 PMCID： PMC5619981 DOI： 10.1681/ASN.2017060663

Source DB: PubMed Journal: J Am Soc Nephrol ISSN： 1046-6673 Impact factor: 10.121

× No keyword cloud information.

11 in total

1. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I).

Authors: Charmaine E Lok; Michael Allon; Louise Moist; Matthew J Oliver; Hemal Shah; Deborah Zimmerman
Journal: J Am Soc Nephrol Date: 2006-09-20 Impact factor: 10.121

2. Vitamin K antagonism aggravates chronic kidney disease-induced neointimal hyperplasia and calcification in arterialized veins: role of vitamin K treatment?

Authors: Emma Zaragatski; Jochen Grommes; Leon J Schurgers; Stephan Langer; Lieven Kennes; Miriam Tamm; Thomas A Koeppel; Jennifer Kranz; Tina Hackhofer; Karen Arakelyan; Michael J Jacobs; Maria Kokozidou
Journal: Kidney Int Date: 2016-03 Impact factor: 10.612

3. Assessing radiocephalic wrist arteriovenous fistulas of obtuse anastomosis using computational fluid dynamics and clinical application.

Authors: Jinkee Lee; Sunho Kim; Sung-Min Kim; Ryungeun Song; Hyun Kyu Kim; Jang Sang Park; Sun Cheol Park
Journal: J Vasc Access Date: 2016-10-22 Impact factor: 2.283

Review 4. A Review of the Hemodynamic Factors Believed to Contribute to Vascular Access Dysfunction.

Authors: Connor V Cunnane; Eoghan M Cunnane; Michael T Walsh
Journal: Cardiovasc Eng Technol Date: 2017-05-19 Impact factor: 2.495

5. Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery.

Authors: Charles E Alpers; Peter B Imrey; Kelly L Hudkins; Tomasz A Wietecha; Milena Radeva; Michael Allon; Alfred K Cheung; Laura M Dember; Prabir Roy-Chaudhury; Yan-Ting Shiu; Christi M Terry; Alik Farber; Gerald J Beck; Harold I Feldman; John W Kusek; Jonathan Himmelfarb
Journal: J Am Soc Nephrol Date: 2017-07-19 Impact factor: 10.121

6. Inhibitory Effect of TLR4 Gene Silencing on Intimal Hyperplasia of Vein Grafting.

Authors: Zhicheng Zhu; Rihao Xu; Xiaomei Zheng; Tiance Wang; Dan Li; Yong Wang; Kexiang Liu
Journal: Vasc Endovascular Surg Date: 2016-09-28 Impact factor: 1.089

7. A new model of an arteriovenous fistula in chronic kidney disease in the mouse: beneficial effects of upregulated heme oxygenase-1.

Authors: Lu Kang; Joseph P Grande; Matthew L Hillestad; Anthony J Croatt; Michael A Barry; Zvonimir S Katusic; Karl A Nath
Journal: Am J Physiol Renal Physiol Date: 2015-12-16

Moving Beyond the Assumed: Improving Fistula Success Rates.

1. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I).

2. Vitamin K antagonism aggravates chronic kidney disease-induced neointimal hyperplasia and calcification in arterialized veins: role of vitamin K treatment?

3. Assessing radiocephalic wrist arteriovenous fistulas of obtuse anastomosis using computational fluid dynamics and clinical application.

Review 4. A Review of the Hemodynamic Factors Believed to Contribute to Vascular Access Dysfunction.

5. Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery.

6. Inhibitory Effect of TLR4 Gene Silencing on Intimal Hyperplasia of Vein Grafting.

7. A new model of an arteriovenous fistula in chronic kidney disease in the mouse: beneficial effects of upregulated heme oxygenase-1.

Review 8. Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis.

9. MicroRNA-221 sponge therapy attenuates neointimal hyperplasia and improves blood flows in vein grafts.

Review 10. The molecular mechanisms of hemodialysis vascular access failure.

1. Supply and Distribution of Vascular Access Physicians in the United States: A Cross-Sectional Study.